Prenatal exposure to maternal pro-inflammatory cytokines shapes memory and immune function in offspring, with sex-specific effects emerging over 50 years.
October 1, 2024
Menu
What You Should Know: Gero, a biotechnology company focused on aging and chronic diseases, has closed $6M in a Series A extension round. This funding
If all goes according to plan, insitro could finally start testing its first drug in clinical trials in 2026, eight years after Daphne Koller founded